232 related articles for article (PubMed ID: 17005513)
1. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies.
Fukuchi K; Ohta H; Matsumura K; Ishida Y
Br J Radiol; 2007 Jan; 80(949):3-11. PubMed ID: 17005513
[TBL] [Abstract][Full Text] [Related]
2. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
3. High intraindividual variability of global myocardial 18F-FDG uptake over time.
Zöphel K; Kotzerke J
J Nucl Med; 2008 Sep; 49(9):1570; author reply 1570-1. PubMed ID: 18703615
[No Abstract] [Full Text] [Related]
4. A 1-week extension of a ketogenic diet provides a further decrease in myocardial
Clément A; Boutley H; Poussier S; Pierson J; Lhuillier M; Kolodziej A; Olivier JL; Karcher G; Marie PY; Maskali F
J Nucl Cardiol; 2020 Apr; 27(2):612-618. PubMed ID: 30128917
[TBL] [Abstract][Full Text] [Related]
5. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.
de Groot M; Meeuwis AP; Kok PJ; Corstens FH; Oyen WJ
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):98-101. PubMed ID: 15605289
[TBL] [Abstract][Full Text] [Related]
6. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
7. Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.
Minamimoto R
Jpn J Radiol; 2021 Jun; 39(6):540-557. PubMed ID: 33517516
[TBL] [Abstract][Full Text] [Related]
8. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
9. Imaging of the myocardium using (18)F-FDG-PET/MRI.
Ferda J; Hromádka M; Baxa J
Eur J Radiol; 2016 Oct; 85(10):1900-1908. PubMed ID: 27470994
[TBL] [Abstract][Full Text] [Related]
10. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
11. Varying degrees of FDG uptake in multiple benign neurofibromas on PET/CT.
Son JM; Ahn MI; Cho KD; Yoo J; Park YH
Br J Radiol; 2007 Sep; 80(957):e222-6. PubMed ID: 17928494
[TBL] [Abstract][Full Text] [Related]
12. Variable cardiac 18FDG patterns seen in oncologic positron emission tomography computed tomography: importance for differentiating normal physiology from cardiac and paracardiac disease.
Maurer AH; Burshteyn M; Adler LP; Gaughan JP; Steiner RM
J Thorac Imaging; 2012 Jul; 27(4):263-8. PubMed ID: 21629130
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography: clinical applications in oncology. Part 1.
Kumar R; Nadig MR; Chauhan A
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
[TBL] [Abstract][Full Text] [Related]
14. Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart.
Masuda A; Naya M; Manabe O; Magota K; Yoshinaga K; Tsutsui H; Tamaki N
Acta Radiol; 2016 Jun; 57(6):661-8. PubMed ID: 26339041
[TBL] [Abstract][Full Text] [Related]
15. Unsuspected hibernating myocardium detected by routine oncology (18)F-FDG PET/CT.
Vilain D; Bochet J; Le Stanc E; Wattel C; Hameg A; Tainturier C
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):409. PubMed ID: 19997913
[No Abstract] [Full Text] [Related]
16. 18F-FDG imaging: pitfalls and artifacts.
Abouzied MM; Crawford ES; Nabi HA
J Nucl Med Technol; 2005 Sep; 33(3):145-55; quiz 162-3. PubMed ID: 16145222
[TBL] [Abstract][Full Text] [Related]
17. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy.
Liu Y; Ghesani NV; Zuckier LS
Semin Nucl Med; 2010 Jul; 40(4):294-315. PubMed ID: 20513451
[TBL] [Abstract][Full Text] [Related]
18. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
Shammas A; Lim R; Charron M
Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
[TBL] [Abstract][Full Text] [Related]
19. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT.
Lobert P; Brown RK; Dvorak RA; Corbett JR; Kazerooni EA; Wong KK
Clin Radiol; 2013 Jan; 68(1):e59-71. PubMed ID: 23177651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
